by Micah Bucy | Mar 20, 2024 | Blog
In December 2023, the FDA received a New Drug Application (NDA) to treat Post-Traumatic Stress Disorder (PTSD). But what makes this application unique is the fact that the proposed drug is MDMA, aka “ecstasy.” MDMA is a Schedule I substance under the Controlled...
by Micah Bucy | Nov 8, 2023 | News, Updates
Last night Ohio overwhelmingly voted (57%-43%) to become the 24th state to legalize cannabis in the United States. What does this mean? The law becomes effective on December 7, 2023. A Division of Cannabis Control is created within the Ohio Department of Commerce to...
by Micah Bucy | Oct 18, 2023 | Firm News & Events
Judith Cassel has been selected as a top 200 lawyer in the 4th edition 22-23 Published 1 September 2023. Read more about the global Top 200 Cannabis Lawyers. Judith’s profile
by Micah Bucy | Oct 13, 2023 | Blog
Mushrooms, ibogaine, ayahuasca, peyote, mescaline, ketamine, MDMA (aka ecstasy), and LSD. These (currently) illicit or heavily regulated hallucinogenic substances could be the next medical breakthrough to treat disorders like PTSD, depression, drug and alcohol...
by Micah Bucy | Sep 3, 2021 | Uncategorized
By Micah Bucy Nearly 10 months after an overwhelming, two-thirds majority of New Jerseyans voted to approve legalizing adult-use/ recreational cannabis, the application window during which New Jerseyans may seek approval to grow, manufacture, wholesale, distribute,...